Hobart Private Capital’s Thermo Fisher Scientific TMO Stock Holding History

Hobart Private Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,546	Closed	-$720K	–	166
2020 Q4	$720K	Buy	1,546 +113	+8%	+$53K	0.32%	52
2020 Q3	$633K	Buy	1,433 +154	+12%	+$63.6K	0.33%	54
2020 Q2	$463K	Buy	1,279 +173	+16%	+$58K	0.26%	95
2020 Q1	$314K	Sell	1,106 -229	-17%	-$72.2K	0.22%	115
2019 Q4	$434K	Buy	1,335 +193	+17%	+$58.5K	0.27%	112
2019 Q3	$333K	Buy	1,142 +42	+4%	+$12K	0.23%	119
2019 Q2	$323K	Buy	+1,100	New	+$303K	0.23%	106

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hobart Private Capital's TMO Position: Q1 2021 in Review

Hobart Private Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2021, closing a stake of 1,546 shares — an estimated $720K sold.

Hobart Private Capital first reported a position in TMO in Q2 2019 and held it in 7 quarters. The position peaked at $720K in Q4 2020. 2,041 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

Hobart Private Capital reported no remaining Thermo Fisher Scientific position as of Q1 2021 after selling out during the quarter.
Hobart Private Capital sold 1,546 Thermo Fisher Scientific shares in Q1 2021, an estimated $720K.
Hobart Private Capital first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 7 quarters.
Hobart Private Capital's Thermo Fisher Scientific position peaked at $720K in Q4 2020.
2,041 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on Hobart Private Capital's 13F filing for Q1 2021, filed 11 Mar 2024.